Developing potentially best-in-class, novel small molecules targeting fundamental biological pathways in cancer
Location: United States, New York
Employees: 51-200
Total raised: $105M
Founded date: 2014
Investors 1
Date | Name | Website |
- | Perceptive... | perceptive... |
Funding Rounds 2
Date | Series | Amount | Investors |
21.05.2020 | Series A | $20M | - |
15.12.2019 | Series C | $85M | - |
Mentions in press and media 8
Date | Title | Description | Source |
27.04.2022 | Zentalis Pharmaceuticals Announces $25 Million Equity Invest... | Zentalis and Pfizer plan to jointly advance the clinical development of ZN-c3, a selective Wee1 inhi... | globenewsw... |
10.08.2021 | Digital health news, funding roundup in the prior week; Augu... | PepGen raised $112.5M; Lucid Lane landed $16M; Kensho Health secured $3.5M; DynamiCare Health picks ... | vator.tv/n... |
02.08.2021 | Zentalis Pharmaceuticals : Zentera Therapeutics Announces Cl... | SHANGHAI, China, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Zentera Therapeutics, a clinical-stage biopharmac... | marketscre... |
21.05.2020 | Zentalis Pharmaceuticals Raises $20M in Series A Financing | Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on... | finsmes.co... |
02.04.2020 | Zentalis Pharmaceuticals had a successful IPO, raising $165M... | - | connect.or... |
15.12.2019 | Zentalis Receives $85M in Funding To Target Cancer | Cancer drug developer Zentalis Pharmaceuticals recently surfaced with an $85 million round... Take 1... | sdbj.com/n... |
09.12.2019 | Zentalis Pharmaceuticals Raises $85M in Series C | NEW YORK, NY, Zentalis Pharmaceuticals announced the completion of an $85 million Series C financi... | vcnewsdail... |
09.12.2019 | Zentalis Pharmaceuticals Raises $85 Million in Oversubscribe... | NEW YORK & SAN DIEGO--(BUSINESS WIRE)--Zentalis Pharmaceuticals, a clinical-stage biopharmaceuti... | citybizlis... |